Tap Into the $65B 'Shroom Boom'

People are rapidly discovering how mushrooms can enhance brain function, gut health, immunity, and more. The only thing holding them back? A simple way to grow them. Hypha Labs built a compact countertop device to solve exactly that.

Confluent (CFLT) Stock Plummets Nearly 30% On Muted Q3 Outlook

Henry Khederian
July 31, 2025

Shares of data-streaming company Confluent Inc (NASDAQ:CFLT) are plunging over 30% in morning trading on Thursday. Here’s what investors need to know.

What To Know: The dramatic sell-off was triggered by the company’s third-quarter guidance, which overshadowed an otherwise solid second-quarter performance.

Confluent reported strong results for the quarter ending June 30, 2025. Total revenue grew 20% year-over-year to $282.3 million, while subscription revenue increased by 21% to $271 million. The company also posted a non-GAAP net income per diluted share of 9 cents, a notable improvement from a loss of 4 cents in the prior year’s quarter.

However, investors were spooked by the company’s forward-looking forecast. For the third quarter, Confluent expects subscription revenue between $281-$282 million and non-GAAP earnings per share of $0.09-$0.10. This guidance was perceived as lackluster by the market, raising concerns about slowing growth momentum.

The weaker outlook prompted a flurry of analyst revisions. Wall Street firms including Baird, Oppenheimer, Raymond James, and Stifel all lowered their price targets on CFLT stock Thursday morning. Stifel also downgraded its rating from Buy to Hold with a new target of $21.

Price Action: According to data from Benzinga Pro, CFLT shares are trading lower by 32.46% to $17.83 Thursday morning. The stock has a 52-week high of $37.90 and a 52-week low of $17.51.

Read Also: Meta’s AI Isn’t Just Smart -- It’s Paying The Bills

How To Buy CFLT Stock

By now you're likely curious about how to participate in the market for Confluent – be it to purchase shares, or even attempt to bet against the company.

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy “fractional shares,” which allows you to own portions of stock without buying an entire share.

In the case of Confluent, which is trading at $17.84 as of publishing time, $100 would buy you 5.61 shares of stock.

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to “go short” a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.

Image: Shutterstock

Continue Reading...

Popular

BlackRock's New ETF BILT Bets On $68 Trillion Boom, But Most Investors Are Missing It

BlackRock debuts first actively managed infrastructure ETF (BILT), highlighting growing interest in this sector. Offers diversity and growth potential.

Apple Surges After-Hours As Q3 Earnings Crush Estimates, iPhone And Services Lead Growth

Apple Inc. shares jumped 2.42% in after-hours trading on Thursday, reaching $212.59, after the iPhone maker delivered third-quarter results that significantly exceeded Wall Street expectations.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Marjorie Taylor Greene Increases These 2 Stocks In Portfolio, Including This AI Name Up Over 100% YTD

Marjorie Taylor Greene has bought stocks multiple times in 2025 and her recent disclosure adds to one of the stocks that drew the biggest red flags in 2025.

Columbia Sportswear sues Columbia University, alleging merchandise too similar and causes confusion

NEW YORK (AP) — For decades, T-shirts, sweatshirts and other clothing under the Columbia Sportswear brand and clothing emblazoned with the Columbia University name coexisted more or less peacefully without confusion.

If You Missed Tesla, Here's Your "Second Chance"... - Ad

If you missed your shot at turning $1,000 into more than $18,000 when I recommended Tesla, you'll want to pay close attention. I'm 100% convinced Elon's "Agenda X" could make early investors rich. But you need to hurry, because Elon and Visa are moments away from launching.

Asian shares retreat after Trump's order imposing new tariffs on 68 countries and the EU

MANILA, Philippines (AP) — Asian shares retreated Friday following that saw more losses as investors assess President Donald Trump's order in seven days.

Enovix Stock Is Tumbling Thursday: What's Going On?

Enovix announces financial results for the second quarter after the market close on Thursday.

Back the Biotech Company Unlocking Mushroom Health Benefits for All - Ad

Functional mushrooms can boost mental, gut, and immune health-but people can't grow them at home. One company is making it easy with a patent-pending kitchen device. Think Nespresso, but for mushrooms. The functional mushroom market is projected to nearly double by 2030.

Meta CFO Susan Li Says Company May Tap External Financing For 2026 AI Infrastructure As CapEx Heads Toward $100 Billion

Meta CFO Susan Li said the company may seek external financing to support its rapidly growing AI infrastructure needs in 2026, with capital expenditures potentially exceeding $100 billion.

NIO Stock Climbs Higher As Investors Await Key Onvo Launch

Shares of Chinese electric vehicle manufacturer NIO are trading higher Thursday. The upward momentum appears to be driven by continued investor optimism ahead of a key product launch.

FDA Submission Expected This Summer - Invest Before It Happens - Ad

This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.

The Latest: US trade partners around the world react to Trump's new tariffs

U.S. trade partners around the world were reacting on Friday to 's executive order that would introduce new tariffs on many of them in seven days, as the global economy and alliances face a fresh test from the president's trade agenda.

How to Hack a $1.3T Market - Ad

Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.

Asian shares are mixed after US stocks fall on weakened hopes for a September interest rate cut

MANILA, Philippines (AP) — Asian shares were mixed on Thursday after most , as doubts rose on Wall Street about whether the Federal Reserve will deliver economy-juicing cuts to interest rates by September.

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

Pilot arrested on child sex abuse material charges after landing at San Francisco airport

SAN FRANCISCO (AP) — A pilot was arrested aboard a Delta Air Lines flight and federal agents took him into custody from the cockpit after the plane landed at San Francisco International Airport.

Ukrainian Parliament approves law ensuring independence of anti-graft watchdogs

KYIV, Ukraine (AP) — Ukraine’s Parliament on Thursday overwhelmingly approved a bill presented by President Volodymyr Zelenskyy that of two of the country’s key anti-corruption watchdogs, reversing his last week that curbed their power and brought an outcry.

What's inside Elon's building in Memphis will shock you - Ad

Inside Elon Musk's Memphis site lies a supercomputer built to power the world's first superhuman AI. It could make Elon a trillionaire - and new millionaires, too. With just $500, you could get in before the September 1st funding window closes.

Corporation for Public Broadcasting to shut down after being defunded by Congress, targeted by Trump

WASHINGTON (AP) — The Corporation for Public Broadcasting, a cornerstone of American culture for three generations, announced Friday it would take steps toward its own closure after being defunded by Congress — marking the end of a nearly six-decade era in which it fueled the production of renowned educational programming, cultural content and even emergency alerts.

Is Elon's Empire Crumbling? - Ad

Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after October 23rd, it may be too late.

Hidden $5 AI Manufacturer Revealed - Ad

The company manufacturing Nvidia's AI servers trades under a secret name. AI revenue: $30B this year. Stock price: $5.

Wallis Annenberg, billionaire philanthropist who backed arts, science and other causes, dies at 86

LOS ANGELES (AP) — Wallis Annenberg, the billionaire philanthropist who supported the arts, science, education and animal welfare causes over decades in Los Angeles, died Monday, her family said.

American Eagle's 'good jeans' ads with Sydney Sweeney spark a debate on race and beauty standards

NEW YORK (AP) — U.S. fashion retailer American Eagle Outfitters wanted to make a splash with its new advertising campaign starring 27-year-old actor . The ad blitz included “clever, even provocative language” and was “definitely going to push buttons,” the company’s chief marketing officer told trade media outlets.

Tap Into the $65B 'Shroom Boom' - Ad

People are rapidly discovering how mushrooms can enhance brain function, gut health, immunity, and more. The only thing holding them back? A simple way to grow them. Hypha Labs built a compact countertop device to solve exactly that.

Beef: It's What's for Dinner — If You Can Afford It

Here's a look at why beef is the latest item driving grocery bills higher.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Who is Erika McEntarfer, the Bureau of Labor Statistics commissioner fired by Trump?

WASHINGTON (AP) — The head of the agency that compiles the closely watched monthly jobs report usually toils in obscurity, but on Friday, the current holder of that job was by the president of the United States.

Alkermes Oral Drug Helps Patients Stay Awake In Mid-Stage Sleep Disorder Study

Alkermes' alixorexton met key endpoints in a Phase 2 trial for narcolepsy type 1, showing strong efficacy and tolerability across all doses.

If You Missed Tesla, Here's Your "Second Chance"... - Ad

If you missed your shot at turning $1,000 into more than $18,000 when I recommended Tesla, you'll want to pay close attention. I'm 100% convinced Elon's "Agenda X" could make early investors rich. But you need to hurry, because Elon and Visa are moments away from launching.

Back the Biotech Company Unlocking Mushroom Health Benefits for All - Ad

Functional mushrooms can boost mental, gut, and immune health-but people can't grow them at home. One company is making it easy with a patent-pending kitchen device. Think Nespresso, but for mushrooms. The functional mushroom market is projected to nearly double by 2030.

Tea-loving Nepal is warming up to coffee

KATHMANDU, Nepal (AP) — Coffee hasn't always been an easy sell in .

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright smartmoneytrading.net
Privacy Policy | Terms of Service